ugichem Receives €2.25 Million funding for Antisense Drug Platform

News   May 29, 2013

 
ugichem Receives €2.25 Million funding for Antisense Drug Platform
 
 
 

RELATED ARTICLES

Consuming Sugary Drinks During Pregnancy May Increase Asthma Risk in Mid-Childhood

News

Children between the ages of 7 and 9 may be at greater risk for developing asthma if they consumed high amounts of fructose in early childhood or their mothers drank a lot of sugar-sweetened beverages while pregnant, according to new research.

READ MORE

Probiotic Gets a Boost from Breast Milk

News

Supplementation with probiotics can improve a person's gut health, but the benefits are often fleeting, and colonization by the probiotic's good microbes usually doesn't last. Breast milk may help sustain those colonies in the long run.

READ MORE

An Anti-Aging Protein Could Be Targeted to Rejuvenate Immune Cells

News

A new study explains what happens when the immune system ages, and has identified two potential new drug targets which could help postpone the development of age-related diseases.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE